Novel Biomarkers for the Diagnosis and Subtyping of Small B-Cell Lymphomas
The accurate diagnosis of the most common small B-cell lymphoma histological subtypes can pose a significant challenge for pathologists. There is an urgent need to address this challenge as the […]
Novel Treatment Strategy for Gastric Cancer
Gastric cancer with the development of peritoneal metastasis (cancer that has spread to the peritoneum) can be an incapacitating disease with poor survival outcome. This disease is usually treated with […]
Improving Patient Selection for Phase I Clinical Trials
Phase I trials are an essential part of bringing new cancer therapies into the clinic. As participation in Phase I trials usually requires life expectancy of greater than 3 months […]
Immunotherapy for Advanced Oesophageal Squamous Cell Carcinoma
Immune checkpoint inhibitors (ICIs), a type of therapy which can greatly enhance the ability of the immune system to recognise and attack cancer cells, have been effective in improving the […]